Proprotein Convertase Is the Highest-Level Activator of the Alternative Complement Pathway in the Blood.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 05 2021
Historique:
received: 29 05 2020
accepted: 01 03 2021
pubmed: 17 4 2021
medline: 26 8 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Factor D (FD) is an essential element of the alternative pathway of the complement system, and it circulates predominantly in cleaved, activated form in the blood. In resting blood, mannose-binding lectin-associated serine protease 3 (MASP-3) is the exclusive activator of pro-FD. Similarly to FD, MASP-3 also circulates mainly in the active form. It was not clear, however, how zymogen MASP-3 is activated. To decipher its activation mechanism, we followed the cleavage of MASP-3 in human hirudin plasma. Our data suggest that neither lectin pathway proteases nor any protease controlled by C1-inhibitor are required for MASP-3 activation. However, EDTA and the general proprotein convertase inhibitor decanoyl-RVKR-chloromethylketone completely prevented activation of exogenous MASP-3 added to blood samples. In this study, we show that proprotein convertase subtilisin/kexin (PCSK) 5 and PCSK6 are able to activate MASP-3 in vitro. Unlike PCSK5, PCSK6 was detected in human serum and plasma, and previously PCSK6 had also been shown to activate corin in the circulation. In all, PCSK6 emerges as the MASP-3 activator in human blood. These findings clarify the very first step of the activation of the alternative pathway and also connect the complement and the proprotein convertase systems in the blood.

Identifiants

pubmed: 33858964
pii: jimmunol.2000636
doi: 10.4049/jimmunol.2000636
doi:

Substances chimiques

MASP1 protein, human EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2198-2205

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Auteurs

Gábor Oroszlán (G)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

Ráhel Dani (R)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

Barbara M Végh (BM)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Department of Biochemistry, Eötvös Loránd University, Budapest, Hungary; and.

Dóra Varga (D)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

Andrea V Ács (AV)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

Gábor Pál (G)

Department of Biochemistry, Eötvös Loránd University, Budapest, Hungary; and.

Péter Závodszky (P)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

Henriette Farkas (H)

Hungarian Angioedema Center of Reference and Excellence, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.

Péter Gál (P)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary; dobo.jozsef@ttk.mta.hu gal.peter@ttk.mta.hu.

József Dobó (J)

Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary; dobo.jozsef@ttk.mta.hu gal.peter@ttk.mta.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH